These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37034476)

  • 21. Artificial intelligence and the future of life sciences.
    Leite ML; de Loiola Costa LS; Cunha VA; Kreniski V; de Oliveira Braga Filho M; da Cunha NB; Costa FF
    Drug Discov Today; 2021 Nov; 26(11):2515-2526. PubMed ID: 34245910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GPT-4, artificial intelligence and implications for publishing.
    Ong CWM; Blackbourn HD; Migliori GB
    Int J Tuberc Lung Dis; 2023 Jun; 27(6):425-426. PubMed ID: 37231608
    [No Abstract]   [Full Text] [Related]  

  • 23. Theme issue "Solid state and solid dosage forms".
    Kleinebudde P
    Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
    [No Abstract]   [Full Text] [Related]  

  • 24. A year in review: artificial intelligence permeates into mainstream statistics in pharmaceutical product development at a laggard pace.
    Gamalo M
    J Biopharm Stat; 2021 Jan; 31(1):1-4. PubMed ID: 33739911
    [No Abstract]   [Full Text] [Related]  

  • 25. Artificial Intelligence for Pharma: Time for Internal Investment.
    Henstock PV
    Trends Pharmacol Sci; 2019 Aug; 40(8):543-546. PubMed ID: 31204059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using ChatGPT to evaluate cancer myths and misconceptions: artificial intelligence and cancer information.
    Johnson SB; King AJ; Warner EL; Aneja S; Kann BH; Bylund CL
    JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 36929393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentials and pitfalls of ChatGPT and natural-language artificial intelligence models for the understanding of laboratory medicine test results. An assessment by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group on Artificial Intelligence (WG-AI).
    Cadamuro J; Cabitza F; Debeljak Z; De Bruyne S; Frans G; Perez SM; Ozdemir H; Tolios A; Carobene A; Padoan A
    Clin Chem Lab Med; 2023 Jun; 61(7):1158-1166. PubMed ID: 37083166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patentability challenges associated with emerging pharmaceutical technologies.
    Aggarwal S; Chandra A
    Pharm Pat Anal; 2021 Jul; 10(4):195-207. PubMed ID: 34253027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift.
    Hopkins AM; Logan JM; Kichenadasse G; Sorich MJ
    JNCI Cancer Spectr; 2023 Mar; 7(2):. PubMed ID: 36808255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Is openness in the drug market possible?].
    Dölle W; Schwabe U
    Internist (Berl); 1986 Jan; 27(1):21-31. PubMed ID: 3514513
    [No Abstract]   [Full Text] [Related]  

  • 31. The ChatGPT (Generative Artificial Intelligence) Revolution Has Made Artificial Intelligence Approachable for Medical Professionals.
    Mesko B
    J Med Internet Res; 2023 Jun; 25():e48392. PubMed ID: 37347508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial intelligence in drug development: present status and future prospects.
    Mak KK; Pichika MR
    Drug Discov Today; 2019 Mar; 24(3):773-780. PubMed ID: 30472429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artificial Intelligence and Pharmaceutical Production.
    Gupta S
    PDA J Pharm Sci Technol; 2023; 77(3):145. PubMed ID: 37290966
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of an open artificial intelligence platform in modern neurosurgical education: a preliminary study.
    Sevgi UT; Erol G; Doğruel Y; Sönmez OF; Tubbs RS; Güngor A
    Neurosurg Rev; 2023 Apr; 46(1):86. PubMed ID: 37059815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advancing Drug Discovery via Artificial Intelligence.
    Chan HCS; Shan H; Dahoun T; Vogel H; Yuan S
    Trends Pharmacol Sci; 2019 Aug; 40(8):592-604. PubMed ID: 31320117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Publishing artificial intelligence research papers: A tale of three journals.
    Shortliffe EH; Peleg M; Combi C; Chang AC; Vinci J
    J Biomed Inform; 2021 Mar; 115():103708. PubMed ID: 33640535
    [No Abstract]   [Full Text] [Related]  

  • 37. Disrupting 3D printing of medicines with machine learning.
    Elbadawi M; McCoubrey LE; Gavins FKH; Ong JJ; Goyanes A; Gaisford S; Basit AW
    Trends Pharmacol Sci; 2021 Sep; 42(9):745-757. PubMed ID: 34238624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Publishing Artificial Intelligence Research Papers: A Tale of Three Journals.
    Shortliffe EH; Peleg M; Combi C; Chang AC; Vinci J
    Artif Intell Med; 2021 Mar; 113():102037. PubMed ID: 33685588
    [No Abstract]   [Full Text] [Related]  

  • 39. The relationship between physicians and the pharmaceutical industry: a report of the Royal College of Physicians.
    Royal College of Physicians
    J R Coll Physicians Lond; 1986 Oct; 20(4):3-10. PubMed ID: 11643936
    [No Abstract]   [Full Text] [Related]  

  • 40. The convergence of artificial intelligence and chemistry for improved drug discovery.
    Green CP; Engkvist O; Pairaudeau G
    Future Med Chem; 2018 Nov; 10(22):2573-2576. PubMed ID: 30499699
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.